SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTC BB: AVRO), a full service international clinical research organization (CRO) specializing in oncology, cardiovascular diseases and medical devices, today announced the appointment of Peter C. Gonze as Executive Vice President of Global Business Development. In this role, he will oversee Averion’s global business development and marketing activities, and will serve on the Company’s Executive Management Team.
